Evidence-Based Complementary and Alternative Medicine
Volume 2019 (2019), Article ID 9791436, 1 page
https://doi.org/10.1155/2019/9791436

Corrigendum

Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”

Yong Wang,¹ Chun Li,¹ Yulin Ouyang,¹ Junda Yu,¹ Shuzhen Guo,¹ Zhongyang Liu,² Dong Li,² Jing Han,¹ and Wei Wang¹

¹Beijing University of Chinese Medicine, Bei San Huan Dong Lu 11, Chao Yang District, Beijing 100029, China
²State Key Laboratory of Proteomics, Beijing Proteome Research Center, Institute of Radiation Medicine, Beijing 100850, China

Correspondence should be addressed to Wei Wang; wangwei26960@126.com

Received 3 April 2018; Accepted 30 April 2018; Published 10 January 2019

Copyright © 2019 Yong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2” [1], the wrong TCM remedy was cited in the Introduction. The article focuses on the pharmacological effect of Qishenyiqi (QSYQ) on coronary heart disease, but two articles about Qishenyiqi drop pill, which has a similar name and the same abbreviation, QSYQ, were inappropriately discussed as references 2 and 3. Both remedies include Radix Astragali mongolici (‘huang-qi’ in Chinese) and Salvia miltiorrhiza bunge (‘dan-shen’ in Chinese).

Therefore, references 2 and 3 and the following wording should be removed from the introduction: “is widely produced in China in accordance with the China pharmacopoeia standard of quality control . It is commonly used in routine treatment of CHD in clinical practice in China. It contains large-scale epidemiological survey in the randomized, controlled clinical trials proved that it has a definite effect on improving heart function .” Accordingly, the first sentence in the first paragraph of the Introduction should read as follows:

“The ancient TCM Qishenyiqi (QSYQ) was prepared from a basic formula of six Chinese herbs (Radix Astragali Mongolici, salvia miltiorrhiza bunge, Flos Lonicerae, scrophularia, Radix Aconiti Lateralis Preparata, and Radix Glycyrrhizae).”

References

Y. Wang, C. Li, Y. Ouyang et al., “Cardioprotective effects of qishenyiqi mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin-converting enzyme 2,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 978127, 9 pages, 2012.